Диссертация (1154882), страница 21
Текст из файла (страница 21)
Cartil. 21:1400– 1408.63.Garcia S, Bernad A, Martín MC, Cigudosa JC, Garcia-Castro J, de laFuente R. Pitfalls in spontaneous in vitro transformation of human mesenchymalstemcellsExpCellRes.2010May15;316(9):1648-50.doi:10.1016/j.yexcr.2010.02.016. Epub 2010 Feb 18.64.Gentile P1, Orlandi A, Scioli MG, Di Pasquali C, Bocchini I, CervelliV.., Concise review: adipose-derived stromal vascular fraction cells and platelet-richplasma: basic and clinical implications for tissue engineering therapies inregenerative surgery. Stem Cells Transl Med, 2012.
1(3): p. 230-6.13765.Goldring MB, Marcu KB. 2009. Cartilage homeostasis in health andrheumatic diseases. Arthritis Res. Ther. 11:224.66.Guilak F. 2011. Biomechanical factors in osteoarthritis. Best Pract. Res.Clin. Rheumatol. 25:815–823.67.Hager G1, Holnthoner W, Wolbank S, Husa AM, Godthardt K, Redl H,Gabriel C.., Three specific antigens to isolate endothelial progenitor cells fromhuman liposuction material. Cytotherapy, 2013. 15(11): p. 1426- 35.68.Hak Chang • Byung-Rok Do • Jeong-Hwan Che • Byeong-Cheol Kang •Ji-Hyang Kim • Euna Kwon • Ji-Young Kim • Kyung-Hee Min.
Safety of AdiposeDerived Stem Cells and Collagenase in Fat Tissue Preparation Aesthetic Plast Surg.2013 Aug;37(4):802-8. doi: 10.1007/s00266-013-0156-7. Epub 2013 Jul 469.Han, S.K., H.R. Kim, and W.K. Kim, The treatment of diabetic footulcers with uncultured, processed lipoaspirate cells: a pilot study. Wound RepairRegen, 2010. 18(4): p. 342-8.70.Hashimoto S, Takahashi K, Amiel D, Coutts RD, Lotz M.
1998.Chondrocyte apoptosis and nitric oxide production during experimentally inducedosteoarthritis. Arthritis Rheum. 41:1266–74.71.Health Quality Ontario. 2005. Arthroscopic lavage and debridement forosteoarthritis of the knee: an evidence-based analysis. Ont. Health Technol. Assess.Ser. 5:1–37.72.Henrotin Y., Bruckner P, Pujol J-P.
2003. The role of reactive oxygenspecies in homeostasis and degradation of cartilage. Osteoarthr. Cartil. 11:747–755.73.Horwitz EM, Le Blanc K, Dominici M, Mueller I, Slaper-Cortenbach I,Marini FC, Deans RJ, Krause DS, Keating A. 2005. Clarification of the nomenclaturefor MSC: The International Society for Cellular Therapy position statement.Cytotherapy 7:393–5.74.Houtgraaf JH, Versmissen J, van der Giessen WJ. A concise review ofDNA damage checkpoints and repair in mammalian cells. Cardiovasc Revasc Med2006; 7:165-17213875.Hunter DJ, Pike MC, Jonas BL, Kissin E, Krop J, McAlindon T. 2010.Phase 1 safety and tolerability study of BMP-7 in symptomatic knee osteoarthritis.BMC Musculoskelet.
Disord. 11:232.76.Hunter DJ, Schofield D, Callander E. 2014. The individual andsocioeconomic impact of osteoarthritis. Nat. Rev. Rheumatol. 10:437–41.77.Intekhab-Alam NY, White OB, Getting SJ, Petsa A, Knight RA,Chowdrey HS, Townsend PA, Lawrence KM, Locke IC. 2013. Urocortin protectschondrocytes from NO-induced apoptosis: a future therapy for osteoarthritis? CellDeath Dis. 4:e717.78.Ishii H, Tanaka H, Katoh K, Nakamura H, Nagashima M, Yoshino S.2002. Characterization of infiltrating T cells and Th1/Th2-type cytokines in thesynovium of patients with osteoarthritis.
Osteoarthritis Cartilage 10:277–81.79.Ito S, Sato M, Yamato M, Mitani G, Kutsuna T, Nagai T, Ukai T,Kobayashi M, Kokubo M, Okano T, Mochida J. 2012. Repair of articular cartilagedefect with layered chondrocyte sheets and cultured synovial cells. Biomaterials33:5278–86.80.Johnstone B, Alini M, Cucchiarini M, Dodge GR, Eglin D, Guilak F,Madry H, Mata A, Mauck RL, Semino CE, Stoddart MJ. 2013.
Tissue engineeringfor articular cartilage repair--the state of the art. Eur. Cell. Mater. 25:248–67.81.Jurgens WJ1, Kroeze RJ, Zandieh-Doulabi B, van Dijk A, Renders GA,Smit TH, van Milligen FJ, Ritt MJ, Helder MN., One-step surgical procedure for thetreatment of osteochondral defects with adipose-derived stem cells in a caprine kneedefect: a pilot study. Biores Open Access, 2013.
2(4): p. 315-25.82.Kapoor M, Martel-Pelletier J, Lajeunesse D, Pelletier J-P, Fahmi H.2011. Role of proinflammatory cytokines in the pathophysiology of osteoarthritis.Nat. Rev. Rheumatol. 7:33–42.83.Kappos EA1,2, Engels PE1,2, Tremp M1,2, Meyer zu SchwabedissenM1,2, di Summa P3, Fischmann A4, von Felten S5, Scherberich A6, Schaefer DJ1,Kalbermatten DF1,2 Peripheral Nerve Repair: Multimodal Comparison of the LongTerm Regenerative Potential of Adipose Tissue-Derived Cells in a Biodegradable139Conduit.
Stem Cells Dev. 2015 Sep 15;24(18):2127-41. doi: 10.1089/scd.2014.0424.Epub 2015 Jul 2.84.Karkabi S, Rosenberg N. 2015. Arthroscopic Debridement with Lavageand Arthroscopic Lavage Only as the Treatment of Symptomatic Osteoarthritic Knee.Open J. Clin. Diagnostics 05:68–73.85.Karsdal MA, Christiansen C, Ladel C, Henriksen K, Kraus VB, Bay-Jensen AC. 2014. Osteoarthritis--a case for personalized health care? OsteoarthritisCartilage 22:7–16.86.Kim YS1, Choi YJ1, Suh DS1, Heo DB1, Kim YI1, Ryu JS1, Koh YG2.., “Mesenchymal stem cell implantation in osteoarthritic knees: is fibrin glue effectiveas a s caffold?” The American Journal of Sports Medicine, vol.
43, no. 1, pp. 176–185, 2015.87.Kleemann RU, Krocker D, Cedraro A, Tuischer J, Duda GN. 2005.Altered cartilage mechanics and histology in knee osteoarthritis: relation to clinicalassessment (ICRS Grade). Osteoarthritis Cartilage 13:958–63.88.Koh Y. G and Y. J. Choi, “Infrapatellar fat pad-derived mesenchymalstem cell therapy for knee steoarthritis,” Knee, vol. 19, no. 6, pp. 902–907, 2012.89.Koh Y.-G., Y.-J. Choi, S.-K. Kwon, Y.-S.
Kim, and J.-E. Yeo, “Clinicalresults and second-look arthroscopic findings after treatment with adipose-derivedstem cells for knee osteoarthritis,” Knee Surgery, Sports Traumatology, Arthroscopy,vol. 23, no. 5, pp. 1308–1316, 2015.90.Koh YG1, Jo SB, Kwon OR, Suh DS, Lee SW, Park SH, Choi YJ. ,“Mesenchymal stem cell injections improve symptoms of knee osteoarthritis,”Arthroscopy, vol.
29, no. 4, pp. 748–755, 2013.91.Koh YJ1, Koh BI, Kim H, Joo HJ, Jin HK, Jeon J, Choi C, Lee DH,Chung JH, Cho CH, Park WS, Ryu JK, Suh JK, Koh GY. ., Stromal vascular fractionfrom adipose tissue forms profound vascular network through the dynamicreassembly of blood endothelial cells. Arterioscler Thromb Vasc Biol, 2011. 31(5): p.114114092.Kojima F, Naraba H, Miyamoto S, Beppu M, Aoki H, Kawai S.
2004.Membrane-associated prostaglandin E synthase-1 is upregulated by proinflammatorycytokines in chondrocytes from patients with osteoarthritis. Arthritis Res. Ther.6:R355–65.93.Kølle SF1, Fischer-Nielsen A, Mathiasen AB, Elberg JJ, Oliveri RS,Glovinski PV, Kastrup J, Kirchhoff M, Rasmussen BS, Talman ML, Thomsen C,Dickmeiss E, Drzewiecki KT.., Enrichment of autologous fat grafts with ex-vivoexpanded adipose tissue-derived stem cells for graft survival: a randomised placebocontrolled trial. Lancet, 2013.
382(9898): p. 1113-20.94.Kurth T, Hedbom E, Shintani N, Sugimoto M, Chen FH, Haspl M,Martinovic S, Hunziker EB. 2007. Chondrogenic potential of human synovialmesenchymal stem cells in alginate. Osteoarthritis Cartilage 15:1178–89.95.Kwon HM1, Hur SM, Park KY, Kim CK, Kim YM, Kim HS, Shin HC,Won MH, Ha KS, Kwon YG, Lee DH, Kim YM.., Multiple paracrine factors secretedby mesenchymal stem cells contribute to angiogenesis. Vascul Pharmacol.
2014Oct;63(1):19-28. doi: 10.1016/j.vph.2014.06.004. Epub 2014 Jul 2.96.Lambert C, Mathy-Hartert M, Dubuc J-E, Montell E, Vergés J, MunautC, Noël A, Henrotin Y. 2012. Characterization of synovial angiogenesis inosteoarthritis patients and its modulation by chondroitin sulfate. Arthritis Res. Ther.14:R58.97.Lanas A, Garcia-Tell G, Armada B, Oteo-Alvaro A. 2011. Prescriptionpatterns and appropriateness of NSAID therapy according to gastrointestinal risk andcardiovascular history in patients with diagnoses of osteoarthritis. BMC Med.
9:38.98.Lee J-C, Min HJ, Park HJ, Lee S, Seong SC, Lee MC. 2013. Synovialmembrane-derived mesenchymal stem cells supported by plateletrich plasma canrepair osteochondral defects in a rabbit model. Arthroscopy 29:1034–46.99.Li J1, Gao J, Cha P, Chang Q, Liao Y, Liu C, Li K, Lu F..,Supplementing fat grafts with adipose stromal cells for cosmetic facial ontouring.Dermatol Surg, 2013. 39(3 Pt 1): p. 449-56.141100.Litwic A, Edwards MH, Dennison EM, Cooper C. 2013.
Epidemiologyand burden of osteoarthritis. Br. Med. Bull. 105:185–199.101.Loeser RF, Goldring SR, Scanzello CR, Goldring MB. 2012a.Osteoarthritis: A disease of the joint as an organ. Arthritis Rheum. 64:1697–1707.102.Loeser RF, Goldring SR, Scanzello CR, Goldring MB. 2012b.Osteoarthritis: A disease of the joint as an organ. Arthritis Rheum. 64:1697– 1707.103.Lohmander LS. 2013. Knee replacement for osteoarthritis: facts, hopes,and fears. Medicographia 35:181–188.104.Luyten FP, Vanlauwe J. 2012. Tissue engineering approaches forosteoarthritis. Bone 51:289–296105.Mandegaran R, Conway C, Elton C. 2013. Lower gastrointestinaladverse effects of NSAIDS: an extreme example of a common problem.
BMJ CaseRep. 2013.106.Mapp PI, Walsh DA. 2012. Mechanisms and targets of angiogenesis andnerve growth in osteoarthritis. Nat. Rev. Rheumatol. 8:390–8.107.Masuoka K, Asazuma T, Hattori H, Yoshihara Y, Sato M, Matsumura K,Matsui T, Takase B, Nemoto K, Ishihara M. 2006. Tissue engineering of articularcartilage with autologous cultured adipose tissue-derived stromal cells usingatelocollagen honeycombshaped scaffold with a membrane sealing in rabbits. J.Biomed.
Mater. Res. B. Appl. Biomater. 79:25–34.108.Mauck RL, Nicoll SB, Seyhan SL, Ateshian GA, Hung CT. 2003.Synergistic action of growth factors and dynamic loading for articular cartilage tissueengineering. Tissue Eng. 9:597–611.109.McAlindon TE, Bannuru RR, Sullivan MC, Arden NK, Berenbaum F,Bierma-Zeinstra SM, Hawker G a., Henrotin Y, Hunter DJ, Kawaguchi H, Kwoh K,Lohmander S, Rannou F, Roos EM, Underwood M. 2014. OARSI guidelines for thenon-surgical management of knee osteoarthritis.
Osteoarthr. Cartil. 22:363–388.110.McDermott ID, Amis AA. 2006. The consequences of meniscectomy. J.Bone Jt. Surg. - Br. Vol. 88-B:1549–1556.142111.Messier SP, Loeser RF, Miller GD, Morgan TM, Rejeski WJ, SevickMA, Ettinger WH, Pahor M, Williamson JD.
2004. Exercise and dietary weight lossin overweight and obese older adults with knee osteoarthritis: the Arthritis, Diet, andActivity Promotion Trial. Arthritis Rheum. 50:1501–10.112.Michalek J1, Moster R, Lukac L, Proefrock K, Petrasovic M, Rybar J,Capkova M, Chaloupka A, Darinskas A, Michalek J Sr, Kristek J, Travnik J,Jabandziev P, Cibulka M, Holek M, Jurik M, Skopalik J, Kristkova Z, Dudasova Z.Cell Transplant. 2015 Jan 20.
doi: 10.3727/096368915X686760. [Epub ahead ofprint] Autologous adipose tissue-derived stromal vascular fraction cells application inpatients with osteoarthritis113.Mongin G. 2007. Tramadol extended-release formulations in themanagement of pain due to osteoarthritis. Expert Rev. Neurother. 7:1775–1784.114.Morrison JB. 1970.
The mechanics of the knee joint in relation to normalwalking. J. Biomech. 3:51–61.115.Mort JS, Beaudry F, Théroux K, Emmott AA, Richard H, Fisher WD,Lee ER, Poole AR, Laverty S. 2016. Early cathepsin K degradation of type IIcollagen in vitro and in vivo in articular cartilage. Osteoarthritis Cartilage:1–9.116.Moseley JB, O’Malley K, Petersen NJ, Menke TJ, Brody BA,Kuykendall DH, Hollingsworth JC, Ashton CM, Wray NP. 2002. A controlled trial ofarthroscopic surgery for osteoarthritis of the knee.
![](https://s.studizba.com/z.php?f=/templates/si/i/noavatar.png&w=100&h=100&t=1"){kind=avatar}
